The Director of Institutional Sales & Education will lead the strategic development and execution of sales and educational initiatives targeting ophthalmology residency programs, fellowship programs, as well as optometry schools and associated residency programs across the U.S. This senior leadership role blends high-level business development with impactful educational programming, ensuring the company’s eye care portfolio is positioned as a preferred choice among future ophthalmologists, optometrists, academic leaders, and key opinion leaders (KOLs). Thea Pharma markets a suite of leading eye-care drugs that have been approved by the U.S. Food and Drug Administration (FDA), including iYUZEH, Zioptan®, Cosopt®, Cosopt PF®, Azasite®, Akten®, and Betimol®, as well as AcellFX Acellular Amniotic Membrane and the portfolio of iVIZIA dry-eye drops and eyelid hygiene products.